Novo Nordisk (NOVOB DC) Wegovy pill recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class; to launch Wegovy pill in select markets outside US in H2 '26

Newsquawk StaffPublished On the live feed at 9 more headlines followed before this page went public
Newsquawk headlinesUTC

Qatar has reportedly sent a negotiating team to Tehran with the US team to help secure a deal to end the Iran war, according to Reuters sources

[MARKET UPDATE] Further risk-on seen after Reuters reported Qater sent a negotiating team to Tehran; DXY and Crude slip, equities, high-beta FX and Fixed bid

Novo Nordisk (NOVOB DC) Wegovy pill recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class; to launch Wegovy pill in select markets outside US in H2 '26

Daily US Equity Opening News - AMD sees tighter CPU market; WDAY, ZM, and ROST rise on earnings beat

Eli Lilly (LLY) foundayo was associated with reduced body weight by up to 13% in adults 65 and older with obesity or overweight; starting July 1st, 2026, medicare beneficiaries can access foundayo through medicare GLP-1 Bridge at USD 50 monthly copay

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free